England’s National Institute for Health and Care Excellence (NICE) has given a second thumbs down to a pair of Alzheimer’s ...

Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both ...

Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both slowed the progression of the memory-robbing illness.

As a consultant physician at UCL Hospitals, I have seen many young people turning up on the wards following a heart attack or ...

Government initiative could help prevent thousands of heart attacks and strokes, researchers say ...

Read this article to learn how to initiate an assessment for dementia in primary care, acute care and care homes.

The National University Health System (NUHS) honours 77 exceptional individuals and four teams driving transformative change ...

This can then result in hair thinning, shedding, and in some cases, loss. Dr Balwi, leading hair surgeon at Elithair, has ...

Obesity strategy should not be built around a single drug Tirzepatide (Mounjaro) has had a remarkable journey to prominence since its UK marketing authorisation in 2023.1 Approved for glycaemic ...

Dosing is based on the person’s weight and the treatment at list price would cost around £510,000 per year for an adult ...